Zyklooxygenasehemmer: Arzneimittelinteraktionen sind unvermeidlich, nur wenige sind (akut) gefährlich

Research output: Contribution to journalComment/DebateContributedpeer-review

Contributors

  • K. Brune - , Friedrich-Alexander University Erlangen-Nürnberg (Author)
  • B. Renner - , Institute of Clinical Pharmacology, Friedrich-Alexander University Erlangen-Nürnberg (Author)
  • R. Maas - , Friedrich-Alexander University Erlangen-Nürnberg (Author)

Abstract

Non-steroidal, anti-inflammatory drugs are the most widely used remedies worldwide. Drug interactions are frequent, life threatening ones are rare: Bleeds on the basis of inhibition of platelet aggregation and loss of organ protection (GI-tract), thrombotic events due to loss of vasoprotection and increased propensity for blood coagulation (stroke), acute kidney failure on the basis of loss of kidney protection by prostaglandins together with stress to the organ and/or drugs interfering with the renal blood flow. Acute liver toxicity is typical for acetaminophen. Whether the risk is increased by other hepatoxic drugs, as diclofenac, is uncertain at present. All risks can be reduced considerably by avoiding problematic drug interactions.

Translated title of the contribution
Cyclooxygenase inhibitors
Adverse drug reactions cannot be avoided but only a few are acutely serious

Details

Original languageGerman
Pages (from-to)1771-1773
Number of pages3
JournalDeutsche Medizinische Wochenschrift
Volume134
Issue number36
Publication statusPublished - 2009
Peer-reviewedYes

External IDs

PubMed 19718601
ORCID /0000-0003-0845-6793/work/139025240

Keywords

ASJC Scopus subject areas

Keywords

  • COX-2 inhibitors, Cyclooxygenase inhibitors, Non-steroidal anti-steroidal antiinflammatory drugs, NSAID